Multidisciplinary approaches to managing cardiogenic shock
The role of EMS, paramedics, pharmacists, and health information systems
Keywords:
cardiogenic shock, acute coronary syndrome, multidisciplinary care, emergency medical services, health information systems, revascularization, pharmacists, paramedicsAbstract
Background: Cardiogenic shock (CS) is a life-threatening condition that arises from the heart's inability to pump sufficient blood, leading to inadequate perfusion of vital organs. It frequently results from acute coronary syndrome (ACS) and is associated with a high mortality rate despite advances in treatment. Managing CS requires a multidisciplinary approach involving emergency medical services (EMS), paramedics, pharmacists, and health information systems. Aim: This article explores the pathophysiology, etiology, and treatment of CS, emphasizing the role of multidisciplinary care teams in improving patient outcomes. Methods: The review synthesizes current literature on CS management, focusing on the contributions of EMS, paramedics, pharmacists, and health information systems in stabilizing hemodynamics, administering pharmacotherapy, and optimizing long-term care. The analysis also examines clinical trial data, risk scoring models, and the effectiveness of early revascularization therapies. Results: Effective CS management hinges on early diagnosis, immediate revascularization, and hemodynamic stabilization through pharmacological agents and mechanical circulatory support (MCS). EMS and paramedics are pivotal in the early detection and transport of CS patients, while pharmacists play a key role in optimizing pharmacotherapy. Health information systems contribute by streamlining communication, data sharing, and decision-making processes.
Downloads
References
Thiele, H, EM Ohman, S Desch et al. 2015. Management of cardiogenic shock. Eur. Heart J. 36: 1223–1230. DOI: https://doi.org/10.1093/eurheartj/ehv051
Harjola, VP, J Lassus, A Sionis et al. 2015. Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur. J. Heart Fail. 17: 501–509. DOI: https://doi.org/10.1002/ejhf.260
Reynolds, HR, and JS Hochman. 2008. Cardiogenic shock: current concepts and improving outcomes. Circulation 117: 686–697. DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.613596
Abbott, JD, HN Ahmed, HA Vlachos et al. 2007. Comparison of outcome in patients with ST-elevation versus non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am. J. Cardiol. 100: 190–195. DOI: https://doi.org/10.1016/j.amjcard.2007.02.083
Buerke, M, H Lemm, S Dietz, and K Werdan. 2011. Pathophysiology, diagnosis, and treatment of infarction-related cardiogenic shock. Herz 36: 73–83. DOI: https://doi.org/10.1007/s00059-011-3434-7
Thiele, H, U Zeymer, FJ Neumann et al. 2013. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet 382: 1638–1645. DOI: https://doi.org/10.1016/S0140-6736(13)61783-3
Hochman, JS, LA Sleeper, JG Webb et al. 2006. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 295: 2511–2515. DOI: https://doi.org/10.1001/jama.295.21.2511
Mebazaa, A, H Tolppanen, C Mueller et al. 2016. Acute heart failure and cardiogenic shock: a multidisciplinary practical guidance. Intensive Care Med. 42: 147–163. DOI: https://doi.org/10.1007/s00134-015-4041-5
Thiele, H, S Desch, JJ Piek et al. 2016. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: design and rationale of CULPRIT-SHOCK trial. Am. Heart J. 172: 160–169. DOI: https://doi.org/10.1016/j.ahj.2015.11.006
Tarvasmaki, T, J Lassus, M Varpula et al. 2016. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality. Crit. Care 20: 208. DOI: https://doi.org/10.1186/s13054-016-1387-1
Ponikowski, P, AA Voors, SD Anker et al. 2016. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur. J. Heart Fail. 18: 891–975. DOI: https://doi.org/10.1002/ejhf.592
De Backer, D, P Biston, J Devriendt et al. 2010. Comparison of dopamine and norepinephrine in the treatment of shock. N. Engl. J. Med. 362: 779–789. DOI: https://doi.org/10.1056/NEJMoa0907118
Thiele, H, U Zeymer, FJ Neumann et al. 2012. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N. Engl. J. Med. 367: 1287–1296. DOI: https://doi.org/10.1056/NEJMoa1208410
Marenzi, G, E Assanelli, J Campodonico et al. 2010. Acute kidney injury in ST-segment elevation acute myocardial infarction complicated by cardiogenic shock at admission. Crit. Care Med. 38: 438–444. DOI: https://doi.org/10.1097/CCM.0b013e3181b9eb3b
Singh, M, J White, D Hasdai et al. 2007. Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial. J. Am. Coll. Cardiol. 50: 1752–1758. DOI: https://doi.org/10.1016/j.jacc.2007.04.101
Published
How to Cite
Issue
Section
Copyright (c) 2017 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
